Effect of Premature Luteinization on the Oocyte Quality in Oocyte Donation Program.

NCT00455949 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2007-04-04

No results posted yet for this study

Summary

Analyze the possible effect of the progesterone levels of the hCG administration on the oocyte embryo quality. The primary endpoint of this study is the pregnancy rate.

Conditions

  • Premature Luteinization

Sponsors & Collaborators

  • Instituto Valenciano de Infertilidad, IVI VALENCIA

    lead OTHER

Principal Investigators

  • Marco Melo, MD · Instituto Valenciano de Infertilidad

Eligibility

Min Age
18 Years
Max Age
34 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00455949 on ClinicalTrials.gov